Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) shares saw unusually-high trading volume on Thursday following a better than expected earnings announcement. Approximately 728,887 shares traded hands during mid-day trading, an increase of 79% from the previous session’s volume of 406,267 shares.The stock last traded at $19.10 and had previously closed at $19.04.
The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. The company had revenue of $3.65 billion during the quarter, compared to analyst estimates of $3.88 billion. Daiichi Sankyo had a return on equity of 18.39% and a net margin of 15.40%.
Analyst Upgrades and Downgrades
Separately, Zacks Research downgraded Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy”.
Daiichi Sankyo Stock Performance
The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The stock’s 50-day moving average price is $21.81 and its 200-day moving average price is $23.51. The company has a market cap of $34.48 billion and a P/E ratio of 17.17.
Daiichi Sankyo Company Profile
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Articles
- Five stocks we like better than Daiichi Sankyo
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
